Publications
Detailed Information
Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Sue K. | - |
dc.contributor.author | Cho, Lisa Y. | - |
dc.contributor.author | Yang, Jae Jeong | - |
dc.contributor.author | Park, Boyoung | - |
dc.contributor.author | Lee, Kun-Sei | - |
dc.contributor.author | Yoo, Keun-Young | - |
dc.contributor.author | Lee, Choon-Taek | - |
dc.contributor.author | Kim, Hyeongsu | - |
dc.contributor.author | Chang, Soung Hoon | - |
dc.date.accessioned | 2012-06-08T00:37:59Z | - |
dc.date.available | 2012-06-08T00:37:59Z | - |
dc.date.issued | 2010-04 | - |
dc.identifier.citation | LUNG CANCER; Vol.68 1; 20-26 | ko_KR |
dc.identifier.issn | 0169-5002 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76895 | - |
dc.description.abstract | We examined whether the strength of the association of cigarette smoking differs according to histological type and gender, and assessed other risk factors, in particular, tuberculosis. We recruited cases from the Korean Academy of Tuberculosis and Respiratory Diseases and controls from Chungju, a local site of the Korean Multi-Center Cancer Cohort. We matched one case to one control for females and two cases to one control for males according to age (<= 44, 45-69, and >= 70 years old). We used unconditional logistic regression to calculate the odds ratio (OR) and 95% confidence interval (Cl) to estimate lung cancer risk by histologic type for males and females separately. The OR (95% Cl) of 40 or more pack-years smoked relative to never smokers was 6.78(4.17-11.00), 3.49(1.83-6.33), and 2.72(1.57-4.72) for males, and 13.72 (3.23-58.18), 12.18(3.12-47.57), and 7.11 (1.78-28.43) for females for squamous cell, adenocarcinoma, and small cell carcinoma, respectively. Among males, the respective OR (95% CI) for past and current history of lung tuberculosis was 3.21 (2.12-4.90), 2.69(1.63-4.45), and 1.52(0.83-2.78), and for females was 2.40 (1.30-4.42), 4.20 (2.75-6.39), and 1.37(0.61-3.06). Our findings provide additional evidence that women are more susceptible to the carcinogenic effects of tobacco, smoking has a higher risk for squamous cell and small cell carcinoma than adenocarcinoma, and tuberculosis is a potential risk factor for certain lung cancer histologic types. (C) 2009 Elsevier Ireland Ltd. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER IRELAND LTD | ko_KR |
dc.subject | Lung cancer | ko_KR |
dc.subject | Histologic type | ko_KR |
dc.subject | Case-control study | ko_KR |
dc.subject | Gender difference | ko_KR |
dc.subject | Lung tuberculosis | ko_KR |
dc.subject | Cigarette smoking | ko_KR |
dc.title | Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control study | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 박수경 | - |
dc.contributor.AlternativeAuthor | 양재정 | - |
dc.contributor.AlternativeAuthor | 박보영 | - |
dc.contributor.AlternativeAuthor | 장성훈 | - |
dc.contributor.AlternativeAuthor | 이건세 | - |
dc.contributor.AlternativeAuthor | 김형수 | - |
dc.contributor.AlternativeAuthor | 유근영 | - |
dc.contributor.AlternativeAuthor | 이춘택 | - |
dc.identifier.doi | 10.1016/j.lungcan.2009.05.017 | - |
dc.citation.journaltitle | LUNG CANCER | - |
dc.description.citedreference | Engels EA, 2009, INT J CANCER, V124, P1183, DOI 10.1002/ijc.24042 | - |
dc.description.citedreference | WANG XR, 2009, CANC CAUSES CONTROL | - |
dc.description.citedreference | BAE J, 2007, J PREV MED PUBLIC HL, V40, P321 | - |
dc.description.citedreference | *KOR NAT STAT OFF, 2006, REP SOC STAT SURV | - |
dc.description.citedreference | Yun YH, 2005, CANCER EPIDEM BIOMAR, V14, P2125, DOI 10.1158/1055-9965.EPI-05-0236 | - |
dc.description.citedreference | Pauk N, 2005, LUNG CANCER-J IASLC, V48, P1, DOI 10.1016/j.lungcan.2004.10.009 | - |
dc.description.citedreference | Twombly R, 2004, J NATL CANCER I, V96, P898 | - |
dc.description.citedreference | Bain C, 2004, J NATL CANCER I, V96, P826, DOI 10.1093/jnci/djh143 | - |
dc.description.citedreference | Yang P, 2002, AM J EPIDEMIOL, V156, P1114, DOI 10.1093/aje/kwf153 | - |
dc.description.citedreference | Sobue T, 2002, INT J CANCER, V99, P245, DOI 10.1002/ijc.10308 | - |
dc.description.citedreference | PARKIN DM, 2002, CA CANC J CLIN, V55, P74 | - |
dc.description.citedreference | BAE JM, 2002, CANC RES TREAT, V34, P77 | - |
dc.description.citedreference | YOO KY, 2002, ASIAN PAC J CANCER P, V3, P85 | - |
dc.description.citedreference | *KOR NAT STAT OFF, 2002, ANN REP CAUS DEATH S | - |
dc.description.citedreference | Brenner AV, 2001, INT J EPIDEMIOL, V30, P118 | - |
dc.description.citedreference | Khuder SA, 2001, LUNG CANCER-J IASLC, V31, P139 | - |
dc.description.citedreference | Lee CT, 2000, LUNG CANCER-J IASLC, V30, P15 | - |
dc.description.citedreference | Jee SH, 1999, INT J EPIDEMIOL, V28, P824 | - |
dc.description.citedreference | Prescott E, 1998, EPIDEMIOLOGY, V9, P79 | - |
dc.description.citedreference | Zang EA, 1996, J NATL CANCER I, V88, P183 | - |
dc.description.citedreference | THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223 | - |
dc.description.citedreference | TAIOLI E, 1994, J NATL CANCER I, V86, P869 | - |
dc.description.citedreference | KOBAYASHI Y, 1994, BBA-GEN SUBJECTS, V1200, P11 | - |
dc.description.citedreference | OHSHIMA H, 1994, MUTAT RES, V305, P253 | - |
dc.description.citedreference | RISCH HA, 1993, AM J EPIDEMIOL, V138, P281 | - |
dc.description.citedreference | AOKI K, 1993, JPN J CLIN ONCOL, V23, P205 | - |
dc.description.citedreference | VANDEWIEL JAG, 1992, BIOCHEM PHARMACOL, V44, P1977 | - |
dc.description.citedreference | BROWNSON RC, 1992, EPIDEMIOLOGY, V3, P61 | - |
dc.description.citedreference | PIEKOSZEWSKI W, 1991, ACTA POL PHARM, V48, P9 | - |
dc.description.citedreference | *KOR NAT STAT OFF, 1990, REP SOC STAT SURV | - |
dc.description.citedreference | YANG CP, 1989, J NATL CANCER I, V81, P1828 | - |
dc.description.citedreference | ADAMI HO, 1989, INT J CANCER, V44, P833 | - |
dc.description.citedreference | KYEREMATEN GA, 1988, DRUG METAB DISPOS, V16, P823 | - |
dc.description.citedreference | GAO YT, 1987, INT J CANCER, V40, P604 | - |
dc.description.citedreference | ZHENG W, 1987, BRIT J CANCER, V56, P501 | - |
dc.description.citedreference | BENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499 | - |
dc.description.citedreference | LUBIN JH, 1984, J NATL CANCER I, V73, P383 | - |
dc.description.citedreference | CHAUDHURI PK, 1982, CANCER LETT, V16, P327 | - |
dc.description.citedreference | AUERBACH O, 1979, CANCER, V43, P636 | - |
dc.description.citedreference | DOLL R, 1976, BRIT MED J, V2, P1525 | - |
dc.description.citedreference | ROSECRAN.JA, 1972, ARCH INT PHARMACOD T, V196, P46 | - |
dc.description.citedreference | RAEBURN C, 1957, BRIT J TUBERC DIS CH, V51, P237 | - |
dc.description.tc | 7 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.